Regulation · Australia

Is MOTS-c legal
in Australia?

Australia’s Poisons Standard, which sets supply controls, does not name MOTS-c. Whether a product may be supplied at all turns on the Therapeutic Goods Act. Here are both instruments and the TGA’s 2026 record.

Short answerRegulation · 6 min read · Updated 18 Nov 2026

MOTS-c is not named in Australia’s Poisons Standard, but that is not an approval: a product’s status turns on the Therapeutic Goods Act. The TGA says a peptide product promoted, supplied or generally used for a therapeutic purpose is regulated as a therapeutic good, that most peptide products are prescription-only medicines, and that importing, advertising, manufacturing and supplying unapproved peptide products is unlawful.

Key takeaways

  • A full-text search of the October 2026 Poisons Standard found no entry for MOTS-c (18 Nov 2026), and we found no TGA statement applying any of its group entries to MOTS-c.
  • The Poisons Standard sets the level of control on a poison’s availability; whether therapeutic goods may be supplied at all is set by the Therapeutic Goods Act 1989.
  • Under section 19B of the Act, importing, exporting, manufacturing or supplying therapeutic goods for use in humans that are not registered, listed, exempt or approved is an offence.
  • The TGA says “research use only” disclaimers alone do not change a product’s regulatory status, permit importation or remove advertising or supply obligations.
  • Sport Integrity Australia, which defines unapproved peptide products as goods not included in the ARTG, gives MOTS-C as an example of an unapproved peptide that is prohibited in sport; WADA names it in class S4.4.1.

01Is MOTS-c in the Poisons Standard?

Not by name. The instrument in force is the Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327). It was made on 28 September, registered on 30 September and commenced on 1 October 2026.

Our search. On 18 November 2026 we searched the instrument’s full text, all 677 pages, for “MOTS”, “mitochondrial”, “12S”, the peptide’s amino-acid sequence, “AMPK” and “AICAR”. None appears. The Standard also has group entries, and we found no TGA statement applying any of them to MOTS-c; we draw no scheduling conclusion of our own.

What the Standard does. Its reader’s guide calls it “a compilation of decisions” on “the classification of poisons into Schedules, as recommendations to Australian States and Territories”, and says: “The scheduling classification sets the level of control on the availability of poisons.” The explanatory statement adds that the Schedules “are incorporated by reference in State and Territory legislation”, which is where supply and possession offences sit.

Scheduling is not approval. The Standard sets controls on availability. Whether a product may be imported, manufactured or supplied at all is a question for the Therapeutic Goods Act 1989, in the next section.

InstrumentWhat it decidesMOTS-c, as of 18 Nov 2026
Poisons Standard, October 2026Which Schedule a substance sits in, and the supply and possession controls that followNot named; no TGA statement applying a group entry found
Therapeutic Goods Act 1989Whether therapeutic goods may be imported, exported, manufactured or supplied for use in humansTurns on how a product is presented and used; a peptide product not included in the ARTG is unapproved, the TGA says
WADA Prohibited ListProhibited substances for athletes under the World Anti-Doping CodeNamed in class S4.4.1, prohibited at all times

02When is a MOTS-c product a therapeutic good?

It depends on how the product is presented and used. Australian law sorts products, not molecules.

The definition. Section 3 of the Therapeutic Goods Act 1989 defines therapeutic goods as goods “represented in any way to be, or that are, whether because of the way in which the goods are presented or for any other reason, likely to be taken to be” for therapeutic use. Therapeutic use includes “influencing, inhibiting or modifying a physiological process in persons”.

The TGA’s reading for peptides. Its peptide products page, last updated on 23 September 2026, says a peptide product is regulated as a therapeutic good if, for example, it is “promoted, supplied or generally used for a therapeutic purpose”. It adds: “While some peptide products are approved for use in Australia, many products promoted online are unapproved therapeutic goods and may be unlawful to import, supply or advertise.” The TGA’s April 2026 advisory states that “peptide products are regulated as therapeutic goods in Australia” and that “Unapproved peptide products are goods which have not been included in the ARTG”, the Australian Register of Therapeutic Goods.

The core offence. Section 19B makes it an offence to import, export, manufacture or supply in Australia therapeutic goods for use in humans unless they are registered or listed, exempt, or approved under sections 19 or 19A. The maximum is 12 months’ imprisonment, 1,000 penalty units or both. It rises to 5 years, 4,000 penalty units or both where use of the goods has caused, or is likely to cause, harm or injury.

Labels. The April 2026 advisory says: “Disclaimers that a product is for ‘research use only’ does not make its supply lawful.” Such disclaimers alone do not “change a product’s regulatory status”, “permit importation” or “remove advertising or supply obligations”. More: what “research use only” means.

Provision or statementWhat it saysSource
Act, s 3Therapeutic goods are judged by how they are represented or presented, and by their likely useTherapeutic Goods Act 1989
Act, s 19B(4)Importing, exporting, manufacturing or supplying unapproved therapeutic goods for use in humans: up to 12 months, 1,000 penalty units or bothTherapeutic Goods Act 1989
Act, s 19B(1)The same, where use has caused or is likely to cause harm or injury: up to 5 years, 4,000 penalty units or bothTherapeutic Goods Act 1989
Research labelsDisclaimers alone do not change regulatory status, permit importation or remove advertising or supply obligationsTGA, 13 Apr 2026
ManufactureIncludes “applying a label to a blank vial, packaging for distribution, and storage of the products before they are in their final state”TGA, 20 Jul 2026

03What has the TGA done about peptide products in 2026?

The TGA’s 2026 statements address unapproved peptide products as a group. Dates and wording come from the TGA documents.

DateWhat the TGA did or said
13 Apr 2026Safety advisory: peptide products are regulated as therapeutic goods, and “research use only” disclaimers do not make supply lawful.
7 May 2026Warns that peptide imports that do not meet importation requirements because of poor or unclear labelling will be referred to the Australian Border Force “to seize and destroy”.
10 Jun 2026Expands its priority focus areas to include unapproved peptide products, “following increased detection of unlawful importation, supply and advertising”.
20 Jul 2026Puts promoters and suppliers of unapproved peptide products on notice, and says labelling a blank vial counts as manufacture.
17 Aug 2026States: “It is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia.”
23 Sep 2026Updates its peptide products page, which explains when a peptide product is regulated as a therapeutic good.
1 Oct 2026The October 2026 Poisons Standard commences. It has no entry for MOTS-c.

The law that would decide a MOTS-c product’s status did not change in 2026. What changed is how actively the TGA polices peptide products. Its releases describe seizures, notices and tests by product type, not compound by compound. For the rules that apply to every peptide, see are peptides legal in Australia?

04How is MOTS-c treated in Australian sport?

WADA’s Prohibited List names MOTS-c in class S4.4.1, metabolic modulators, among activators of the AMP-activated protein kinase (AMPK). The class is prohibited in and out of competition, and the List says substances in S4.4 are non-Specified Substances.

Sport Integrity Australia’s peptides page says “Many unapproved peptides are prohibited in sport” and gives MOTS-C among its “common examples”. It defines unapproved peptide products as goods not included in the ARTG. It says possession or use of prohibited peptide products by athletes can lead to an anti-doping rule violation and a ban from sport, and that “A TUE is unlikely to be granted for an unregistered medicine”, a TUE being a therapeutic use exemption. Detail: is MOTS-c banned in sport?

05What we don’t know

The ARTG itself. We could not search the ARTG, because tga.gov.au did not respond to our tools on 18 November 2026. The TGA pages cited here were read on the Internet Archive.

Scheduling proposals. We did not search the TGA’s scheduling consultations for MOTS-c, so we cannot say whether a delegate has considered it.

State and territory detail. Poisons and therapeutic goods laws differ by jurisdiction, and we have not summarised them.

Compound-level enforcement. The TGA’s releases do not report actions compound by compound.

For the UK and US positions, see is MOTS-c legal in the UK? and is MOTS-c legal in the US? The evidence on MOTS-c itself is in our MOTS-c research guide. Changes are logged in our regulatory changelog.

This is a plain-English summary of public documents, checked on 18 Nov 2026. It is not legal advice.

RefSources

  1. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327): reader’s guide, Schedules, Appendices and index; full-text search for MOTS-c names. Federal Register of Legislation, made 28 Sep, registered 30 Sep, commenced 1 Oct 2026; 677-page PDF read 18 Nov 2026. www.legislation.gov.au/F2026L01327/latest/text
  2. Explanatory Statement to the Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026. Federal Register of Legislation, registered 30 Sep 2026; read 18 Nov 2026. api.prod.legislation.gov.au/v1/Documents(titleId='F2026L0132…
  3. Therapeutic Goods Act 1989, section 3 (definitions) and section 19B. Federal Register of Legislation, Compilation No. 89 (5 Sep 2025), the latest; read 18 Nov 2026. www.legislation.gov.au/C2004A03952/latest/text
  4. TGA. Peptide products. Topic page, last updated 23 Sep 2026; read on the Internet Archive capture of 5 Nov 2026, the newest (tga.gov.au did not respond on 18 Nov 2026). www.tga.gov.au/resources/explore-topic/peptide-products
  5. TGA. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. Safety advisory, 13 Apr 2026; read on the Internet Archive capture of 10 Aug 2026, the newest. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  6. TGA. TGA warning on the risks of importing unapproved peptide products. Safety alert, 7 May 2026; read on the Internet Archive capture of 25 Jul 2026, the newest. www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  7. TGA. TGA strengthens compliance focus on unapproved peptide products as part of evolving risk response. Media release, 10 Jun 2026; read on the Internet Archive capture of 29 Oct 2026, the newest. www.tga.gov.au/news/media-releases/tga-strengthens-complianc…
  8. TGA. Unapproved peptide product promoters and suppliers are put on notice. Media release, 20 Jul 2026; read on the Internet Archive capture of 12 Sep 2026, the newest. www.tga.gov.au/news/media-releases/unapproved-peptide-produc…
  9. TGA. TGA flexes its muscle against illegal peptides and steroids. Media release, 17 Aug 2026; read on the Internet Archive capture of 11 Oct 2026, the newest. www.tga.gov.au/news/media-releases/tga-flexes-its-muscle-aga…
  10. Therapeutic Goods Administration. TGA testing finds unapproved peptides do not contain what their labels claim (consumer information: “Most peptide products … are prescription-only medicines in Australia”). Safety advisory, 5 Nov 2026; read on the Internet Archive capture of 15 Nov 2026, the newest (tga.gov.au did not respond). www.tga.gov.au/safety/safety-monitoring-and-information/safe…
  11. Sport Integrity Australia. Peptides. Substance education page; read on the Internet Archive capture of 5 Nov 2026, the newest (sportintegrity.gov.au did not respond). www.sportintegrity.gov.au/what-we-do/anti-doping/substance-e…
  12. World Anti-Doping Agency. The Prohibited List 2026 and 2027, class S4 (S4.4.1). International Standard (2026 List in force since 1 Jan 2026; 2027 List takes effect 1 Jan 2027); both PDFs read 18 Nov 2026. www.wada-ama.org/en/prohibited-list

Plain-English summary of public sources, not legal or medical advice. Last checked 18 Nov 2026.

Questions

Is MOTS-c prescription-only in Australia?

The TGA says most peptide products are prescription-only medicines in Australia, naming BPC-157, TB-500 and melanotan I, and that importing, advertising, manufacturing and supplying unapproved peptide products is unlawful. The October 2026 Poisons Standard does not name MOTS-c, and we draw no scheduling conclusion of our own.

Does a “research use only” label change MOTS-c’s status in Australia?

No. The TGA says such disclaimers alone do not change a product’s regulatory status, permit importation or remove advertising and supply obligations.

Is MOTS-c on the ARTG?

We could not search the ARTG on 18 November 2026. Sport Integrity Australia, which defines unapproved peptide products as goods not included in the ARTG, gives MOTS-C as an example of an unapproved peptide prohibited in sport. That is its statement; we have not checked the register ourselves.

Is MOTS-c prohibited in Australian sport?

Yes. WADA names it in class S4.4.1, prohibited at all times, and Sport Integrity Australia gives MOTS-C as an example of an unapproved peptide that is prohibited in sport.

Who enforces the rules on peptide products in Australia?

The TGA, under the Therapeutic Goods Act 1989. It says it will notify the Australian Border Force to seize and destroy poorly labelled peptide imports, and states and territories give the Poisons Standard effect in their own laws.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page